{"abstract": "Capstone Therapeutics, a small biotechnology firm, has developed a radical new therapy \u2014 for investors, Breakingviews says. The company itself is effectively adapting a biological process called apoptosis, a preprogrammed cell suicide of sorts. Under the proposal, shareholders would be given put options that could be redeemed for their proportional amount of the company\u2019s cash. It\u2019s a minor scientific breakthrough, according to the publication.", "web_url": "https://dealbook.nytimes.com/2010/03/24/for-one-biotech-an-expiration-date-with-a-twist/", "snippet": "Capstone Therapeutics, a small biotechnology firm, has developed a radical new therapy \u2014 for investors, Breakingviews says. The company itself is effectively adapting a biological process called apoptosis, a preprogrammed cell suicide of sorts. Un...", "lead_paragraph": "Capstone Therapeutics, a small biotechnology firm, has developed a radical new therapy\u00a0 for investors, Breakingviews says.", "source": "The New York Times", "multimedia": [], "headline": {"main": "For One Biotech, an Expiration Date With a Twist", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Biotechnology", "rank": 1, "major": "N"}], "pub_date": "2010-03-24T08:30:31+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/314ad848-3aa1-5731-aca5-18c6dce62573", "word_count": 346, "uri": "nyt://article/314ad848-3aa1-5731-aca5-18c6dce62573"}